Numbness persists after injections
Dear Dr. Roach: I was in excellent health until December 2020, when I was admitted to the hospital with high-risk multiple myeloma (MM). I’ve been participating in a Phase 2 clinical trial since January 2021, and I was fortunate to achieve minimal residual disease (MRD)-negative status in November 2023 — a milestone that is reached by only 10% of over 20 participants. However, as a side effect of four years of treatment, including Velcade injections (16 total), I’ve developed neuropathy, mainly in my feet. My primary issue is overall numbness and a lack of feeling in my feet. ...